Aytu BioScience Inc (AYTU) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $2.05 (+2.50%), Market cap $0.02B, 52-week low–high $1.49 ~ $2.90.
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT extended-release orally disintegrating tablets for patients from six to seventeen years old; and Metadate CD, a central nervous system stimulant indicated for the treatment of ADHD. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspe
Financial statements, price targets, institutional (13F) holdings and related news for Aytu BioScience Inc are updated in real time on BlackAll Trade.
Aytu BioScience Inc trades at $2.05 (+2.50%). Real-time quotes and charts are available on BlackAll Trade.
Aytu BioScience Inc has a market cap of about $0.02B.
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of at